$90.67
0.25% yesterday
Nasdaq, Nov 25, 10:00 pm CET

ePlus inc. Stock News

Positive
The Motley Fool
18 days ago
It notched a beat-and-raise fiscal second quarter. It's also modeling double-digit increases in key fundamentals for the full fiscal year.
Neutral
Seeking Alpha
19 days ago
ePlus inc. ( PLUS ) Q2 2026 Earnings Call November 6, 2025 4:30 PM EST Company Participants Amanda Dupree Mark Marron - CEO, President & Director Elaine Marion - Chief Financial Officer Conference Call Participants Margaret Nolan - William Blair & Company L.L.C., Research Division Gregory Burns - Sidoti & Company, LLC Presentation Operator Good day, ladies and gentlemen.
Neutral
PRNewsWire
19 days ago
Raises Fiscal 2026 Guidance Amid Double Digit Growth Year Over Year in Second Quarter Revenue, Gross Profit, Net Earnings and Earnings Per Share ~Announces Common Stock Quarterly Dividend of $0.25 Per Share ~ Second Quarter Fiscal Year 2026 Consolidated net sales increased 23.4% to $608.8 million; services revenues increased 19.4% to $123.8 million. Gross billings increased 26.5% to $1,022.7 mi...
Neutral
PRNewsWire
26 days ago
HERNDON, Va., Oct. 30, 2025 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS – news) today announced that on November 6, 2025, it will release earnings and host a conference call regarding its financial results for the three and six months ended September 30, 2025. Earnings will be released after the market closes, and management will hold a conference call and audio webcast at 4:30 p.m. ET.
Neutral
PRNewsWire
about one month ago
Nearly Three Out of Four IT and Industry Leaders Now Prioritize Revenue Growth as Main Driver of AI Initiatives, Over Cost Savings and Increased Customer Satisfaction HERNDON, Va. , Oct. 21, 2025 /PRNewswire/ -- ePlus inc.
Neutral
PRNewsWire
about 2 months ago
Provides Simplified Operational Support and Increased Visibility Across the Network HERNDON, Va. , Sept. 30, 2025 /PRNewswire/ -- ePlus inc.
Positive
24/7 Wall Street
2 months ago
Shares of clinical-stage pharmaceutical company, Plus Therapeutics, are up about 31% on a volume spike of 216.4 million
Neutral
Seeking Alpha
2 months ago
ePlus inc. (NASDAQ:PLUS ) Q1 2026 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Elaine D. Marion - Chief Financial Officer Kleyton L.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today